| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000025689 |
| Receipt No. | R000029554 |
| Scientific Title | Relationship between forced oscillation technique and asthma control or fractional exhaled nitric oxide in adult asthma |
| Date of disclosure of the study information | 2017/01/16 |
| Last modified on | 2020/07/21 (Ver. 7) |
| Basic information | ||
| Public title | Relationship between forced oscillation technique and asthma control or fractional exhaled nitric oxide in adult asthma
|
|
| Acronym | Relationship between forced oscillation technique and asthma control or fractional exhaled nitric oxide | |
| Scientific Title | Relationship between forced oscillation technique and asthma control or fractional exhaled nitric oxide in adult asthma
|
|
| Scientific Title:Acronym | Relationship between forced oscillation technique and asthma control or fractional exhaled nitric oxide | |
| Region |
|
|
| Condition | ||
| Condition | Bronchial asthma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify relationship between forced oscillation technique and asthma control or fractional exhaled nitric oxide |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Difference in forced oscillation technique between patients with and without controlled asthma |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with asthma | |||
| Key exclusion criteria | case which family doctor judged to be unsuitable as experimental object | |||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shizuoka General Hospital | ||||||
| Division name | Department of Respiratory Medicine | ||||||
| Zip code | 4208527 | ||||||
| Address | 4-27-1 Kita-ando, Aoi, Shizuoka | ||||||
| TEL | 054-247-6111 | ||||||
| toshihiro-shirai@i.shizuoka-pho.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shizuoka General Hospital | ||||||
| Division name | Department of Respiratory Medicine | ||||||
| Zip code | 4208527 | ||||||
| Address | 4-27-1 Kita-ando, Aoi, Shizuoka | ||||||
| TEL | 054-247-6111 | ||||||
| Homepage URL | |||||||
| taisuke-akamatsu@i.shizuoka-pho.jp | |||||||
| Sponsor | |
| Institute | Department of Respiratory Medicine, Shizuoka General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shizuoka General Hospital Research Support Office |
| Address | 4-27-1 Kita Ando Aoi-ku, Shizuoka City Japan |
| Tel | 054-247-6111 |
| chiken-sougou@shizuoka-pho.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 静岡県立総合病院(静岡県)、平松内科(愛知県)、古井医院(岐阜県)、はなさきクリニック(愛知県)、近畿大学病院(大阪府)
|
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://doi.org/10.1111/all.14484 |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://doi.org/10.1111/all.14484 | ||||||
| Number of participants that the trial has enrolled | 143 | ||||||
| Results | Oscillometric parameters, including R5, R5-R20, X5, Fres, and AX, but not FEV1, significantly worsened after a 3-month period of observation in the high FeNO group but not in the low FeNO group. FeNO decreased significantly in the high FeNO group but not in the low FeNO group. There were correlations between baseline FeNO levels and changes in R5 and R5-R20 in the high FeNO group. Multiple logistic regression analysis revealed that R5 and R5-R20 were associated with higher FeNO levels. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Of the 97 subjects who completed the study, 28 (28.9%) patients had FeNO levels > 35 ppb. There was no difference in the demographic, ACT, and lung function data between high and low FeNO groups at baseline except for FeNO levels |
||||||
| Participant flow | One hundred and forty-three patients were screened and 46 patients were excluded upon entry because of asthma exacerbation, a change in medications, or difficulty in taking measurements. |
||||||
| Adverse events | none |
||||||
| Outcome measures | The patients were classified into high or low FeNO groups (FeNO > 35 ppb or < 35 ppb) based on the baseline FeNO levels. The primary outcomes were the changes in oscillometric parameters. |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Continue or change the treatment baed on asthma control at baseline (week0).
Evaluate asthma control after 4-12 weeks. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029554 |